Literature DB >> 11863439

Structural basis for the recognition of a bisphosphorylated MAP kinase peptide by human VHR protein Phosphatase.

Maria A Schumacher1, Jacob L Todd, Adrian E Rice, Kirk G Tanner, John M Denu.   

Abstract

Human VHR (vaccinia H1 related phosphatase) is a member of the dual-specificity phosphatases (DSPs) that often act on bisphosphorylated protein substrates. Unlike most DSPs, VHR displays a strong preference for dephosphorylating phosphotyrosine residues over phosphothreonine residues. Here we describe the 2.75 A crystal structure of the C124S inactive VHR mutant in complex with a bisphosphorylated peptide corresponding to the MAP kinase activation lip. This structure and subsequent biochemical studies revealed the basis for the strong preference for hydrolyzing phosphotyrosine within bisphosphorylated substrates containing -pTXpY-. In the structure, the two phospho residues are oriented into distinct pockets; the phosphotyrosine is bound in the exposed yet deep active site cleft while the phosphothreonine is loosely tethered into a nearby basic pocket containing Arg(158). As this structure is the first substrate-enzyme complex reported for the DSP family of enzymes, these results provide the first glimpse into how DSPs bind their protein substrates.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11863439     DOI: 10.1021/bi015799l

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  30 in total

1.  The structure of the cell cycle protein Cdc14 reveals a proline-directed protein phosphatase.

Authors:  Christopher H Gray; Valerie M Good; Nicholas K Tonks; David Barford
Journal:  EMBO J       Date:  2003-07-15       Impact factor: 11.598

2.  Structural analysis of human dual-specificity phosphatase 22 complexed with a phosphotyrosine-like substrate.

Authors:  George T Lountos; Scott Cherry; Joseph E Tropea; David S Waugh
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2015-01-28       Impact factor: 1.056

3.  A genetically encoded sulfotyrosine for VHR function research.

Authors:  Yueting Zheng; Xiaoxuan Lv; Jiangyun Wang
Journal:  Protein Cell       Date:  2013-10       Impact factor: 14.870

4.  Structure of human dual-specificity phosphatase 27 at 2.38 Å resolution.

Authors:  George T Lountos; Joseph E Tropea; David S Waugh
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2011-04-16

5.  Structural and functional analysis of PTPMT1, a phosphatase required for cardiolipin synthesis.

Authors:  Junyu Xiao; James L Engel; Ji Zhang; Mark J Chen; Gerard Manning; Jack E Dixon
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-05       Impact factor: 11.205

Review 6.  Protein tyrosine phosphatases--from housekeeping enzymes to master regulators of signal transduction.

Authors:  Nicholas K Tonks
Journal:  FEBS J       Date:  2013-01-17       Impact factor: 5.542

7.  Specificity profiling of dual specificity phosphatase vaccinia VH1-related (VHR) reveals two distinct substrate binding modes.

Authors:  Rinrada Luechapanichkul; Xianwen Chen; Hashem A Taha; Shubham Vyas; Xiaoyan Guan; Michael A Freitas; Christopher M Hadad; Dehua Pei
Journal:  J Biol Chem       Date:  2013-01-15       Impact factor: 5.157

8.  Overproduction, purification and structure determination of human dual-specificity phosphatase 14.

Authors:  George T Lountos; Joseph E Tropea; Scott Cherry; David S Waugh
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-09-16

9.  Structural basis of substrate recognition by hematopoietic tyrosine phosphatase.

Authors:  David A Critton; Antoni Tortajada; Geoffrey Stetson; Wolfgang Peti; Rebecca Page
Journal:  Biochemistry       Date:  2008-12-16       Impact factor: 3.162

10.  Multidentate small-molecule inhibitors of vaccinia H1-related (VHR) phosphatase decrease proliferation of cervix cancer cells.

Authors:  Shuangding Wu; Sofie Vossius; Souad Rahmouni; Ana V Miletic; Torkel Vang; Jesus Vazquez-Rodriguez; Fabio Cerignoli; Yutaka Arimura; Scott Williams; Tikva Hayes; Michel Moutschen; Stefan Vasile; Maurizio Pellecchia; Tomas Mustelin; Lutz Tautz
Journal:  J Med Chem       Date:  2009-11-12       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.